Cladribine Intravenous and Insulin aspart and insulin degludec Subcutaneous
Determining the interaction of Cladribine Intravenous and Insulin aspart and insulin degludec Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cladribine
Brand name: Mavenclad, Leustatin
Synonyms: Cladribine
Generic Name: insulin aspart / insulin degludec
Brand name: Ryzodeg 70/30 FlexTouch
Synonyms: Insulin aspart and insulin degludec (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cladribine Intravenous-Insulin Aspart Injection
- Cladribine Intravenous-Insulin Aspart Protamine and Insulin Aspart
- Cladribine Intravenous-Insulin aspart protamine and insulin aspart Subcutaneous
- Cladribine Intravenous-Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens)
- Cladribine Intravenous-Insulin Aspart Protamine and Insulin Aspart (Vials)
- Cladribine Intravenous-Insulin Aspart Protamine Injection
- Insulin aspart and insulin degludec Subcutaneous-Cladribine Tablets
- Insulin aspart and insulin degludec Subcutaneous-Claforan
- Insulin aspart and insulin degludec Subcutaneous-Claforan in D5W
- Insulin aspart and insulin degludec Subcutaneous-Claravis
- Insulin aspart and insulin degludec Subcutaneous-Clarifoam EF
- Insulin aspart and insulin degludec Subcutaneous-Clarinex